Animalcare Group (ANCR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 165.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 200.00
  • 52 Week Low: 115.00
  • Currency: UK Pounds
  • Shares Issued: 60.04m
  • Volume: 14,828
  • Market Cap: £99.06m

Animalcare swings to loss as costs outweigh revenue jump

By Duncan Ferris

Date: Tuesday 30 Apr 2019

LONDON (ShareCast) - (Sharecast News) - Animalcare Group on Tuesday swung to an annual loss after delayed product launches and cost increases offset the impact of double-digit revenue growth.
The veterinary sales and marketing organisation recorded a loss before tax of £0.4m for 2018, compared to a profit before tax of £0.4m the year before, despite revenue having increased by 16% to £72.5m, or 2.7% on a proforma basis, as revenue from the Companion Animals division increased by 6% to £44.5m.

However, this jump in revenue was offset by higher costs, including a 70% increase in research and development expenses to £4.8m and a 21% increase in general and administrative expenses to £16.7m.

The AIM traded company said that overall growth was also impacted by some out of stocks due to supply chain challenges, delays in approvals for new products and the pace of the decline in antibiotic prescribing.

Jan Boone, chairman of Animalcare, said: "Animalcare made good progress in 2018 as we focus on creating a competitive platform for future growth in the global animal health sector. We continue to improve the underlying profitability of the group, and the disposal of our Wholesale Division was in line with our strategy to focus on the higher-margin veterinary pharmaceuticals business, a key growth driver."

The company also bolstered its pharmaceuticals division with the appointment of AstraZeneca veteran Jenny Winter as chief executive, who has identified a path for the business following a full review.

Following the review, the company will build itself as a business focused around core therapy areas and higher margin products with the vet as its primary customer, aiming to grow quickly and improve cash generation to enable investment in future growth and innovation.

"Our goal is to deliver sustainable and profitable growth and to achieve this, we will focus on meeting the needs of vets in therapeutic areas where we have existing strengths and can further add value. Improving cash generation is a key focus for the business and we will continue to drive improvements in supply chain efficiency and closely monitor our cost base, whilst selectively investing in future innovation," said Winter.

Animalcare Group's shares were up 3.89% at 147.00p at 0921 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ANCR Market Data

Currency UK Pounds
Share Price 165.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 200.00
52 Week Low 115.00
Volume 14,828
Shares Issued 60.04m
Market Cap £99.06m

ANCR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.53% above the market average25.53% above the market average25.53% above the market average25.53% above the market average25.53% above the market average
96.55% above the sector average96.55% above the sector average96.55% above the sector average96.55% above the sector average96.55% above the sector average
Price Trend
12.47% below the market average12.47% below the market average12.47% below the market average12.47% below the market average12.47% below the market average
25.42% above the sector average25.42% above the sector average25.42% above the sector average25.42% above the sector average25.42% above the sector average
Income
19.57% below the market average19.57% below the market average19.57% below the market average19.57% below the market average19.57% below the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth
6.66% below the market average6.66% below the market average6.66% below the market average6.66% below the market average6.66% below the market average
2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ANCR Dividends

  Latest Previous
  Interim Final
Ex-Div 24-Oct-19 06-Jun-19
Paid 22-Nov-19 05-Jul-19
Amount 2.00p 2.40p

Trades for 18-Oct-2019

Time Volume / Share Price
15:52 10,000 @ 165.00p
15:29 3,043 @ 162.55p
14:35 1,785 @ 170.00p

ANCR Key Personnel

CFO Chris Brewster
CEO Jenny Winter

Top of Page